However, like AHR, HIF can be both pro- and anti-tumourigenic depending upon the setting, and in ccRCC, HIF-2 promotes tumour growth, whereas HIF-1 is tumour suppressive. The gene discussed is AHR; the disease is nonpapillary renal cell carcinoma.